Drugs and nutrition: How side effects can influence nutritional intake

Proceedings of the Nutrition Society

Volumn 69, Issue 4, 2010, Pages 558-564

  White, Rebecca ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Drug therapy; Drug nutrient interactions; Nutritional intake; Side effects; Smell disturbances; Taste disturbances

Indexed keywords

ALENDRONIC ACID; AMANTADINE; ANABOLIC AGENT; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CODEINE; CYTOTOXIC AGENT; DIGOXIN; DRUG; FLUOXETINE; IRON; LEVODOPA; LITHIUM; METFORMIN; MORPHINE; NEUROLEPTIC AGENT; NORTRIPTYLINE; ONDANSETRON; ORAL CONTRACEPTIVE AGENT; OXYBUTYNIN; PENICILLAMINE; PHENELZINE; POTASSIUM; PROPANTHELINE BROMIDE; RISEDRONIC ACID; STEROID; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID;

AGEUSIA; ANOREXIA; APPETITE; CATABOLISM; CONFERENCE PAPER; DIARRHEA; DIETARY INTAKE; DISEASE SEVERITY; DRUG BIOAVAILABILITY; FOOD INTAKE; FOOD PROCESSING; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOGEUSIA; MOTOR DYSFUNCTION; NAUSEA AND VOMITING; NUTRIENT; NUTRITION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PRESCRIPTION; SIDE EFFECT; STOMACH MOTILITY; TASTE DISORDER; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

APPETITE; DRUG THERAPY; FOOD-DRUG INTERACTIONS; GASTROINTESTINAL DISEASES; HUMANS; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PHARMACEUTICAL PREPARATIONS;

EID: 79951955004     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665110001989     Document Type: Conference Paper

References (45)

1. Boullata JI, Armenti VA (editors) (2004) Handbook of Drug-Nutrient Interactions. Totowa, NJ: Humana Press.
2. White R (2010) Drug nutrient interactions. In Advancing Dietetics and Clinical Nutrition [A Payne and HM Barker, editors]. Churchill Livingstone. (In the Press.)
3. Tsakaris P, Oelke M, Michel MC (2008) Drug-induced urinary incontinence. Drugs Aging 25, 541-549. (Pubitemid 351918797)
4. Poon IO, Braun U (2005) High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther 30, 173-178. (Pubitemid 41583613)
5. Darowski A, Chambers SA, Chambers DJ (2009) Antidepressants and falls in the elderly. Drugs Aging 26, 381-394.
6. Jung H, Peregrina AA, Rodriguez JM et al. (1997). The influence of coffee with milk and tea with milk on the bioavailability of tetracycline. Biopharm Drug Dispos 18, 459-463. (Pubitemid 27288375)
7. Porras AG, Holland SD, Gertz BJ (1999) Pharmacokinetics of alendronate. Clin Pharmacokinet. 36, 315-328. (Pubitemid 29261508)
8. Bachmann CG, Zapf A, Brunner E et al. (2009) Dopaminergic treatment is associated with decreased body weight in patients with Parkinsońs disease and dyskinesias. Eur J Neurol 16, 895-901.
9. Graham KA, Gu H, Lieberman JA et al. (2005) Doubleblind, placebo-controlled investigation of amantadine for weight loss in subjects who gained weight with olanzapine. Am J Psychiatry 162, 1744-1746. (Pubitemid 41318248)
10. Li HF, Zou Y, Xia ZZ et al. (2009) Effects of topiramate on weight and metabolism in children with epilepsy. Acta Paediatr 98, 1521-1525.
11. Wirshing DA (2004) Schizophrenia and obesity: impact of antipsychotic medications. J Clin Psychiatry 65, Suppl. 18, 13-26.
12. Alvarez-Jiménez M, González-Blanch C, Crespo-Facorro B et al. (2008) Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal. CNS Drugs 22, 547-562. (Pubitemid 351822117)
13. Alvarez-Jiménez M, Martínez-García O, Pérez-Iglesias R et al. (2010) Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial. Schizophr Res 116, 16-19.
14. Taylor FR (2008) Weight change associated with the use of migraine-preventive medications. Clin Ther 30, 1069-1080. (Pubitemid 351978119)
15. Bigal ME, Lipton RB (2006) Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 67, 252-257. (Pubitemid 44305408)
16. Yeh SS, Lovitt S, Schuster MW (2009) Use of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly. J Nutr Health Aging 13, 448-454.
17. Berenstein EG, Ortiz Z (2005) Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev 18, CD004310.
18. Pascual López A, Roqué i Figuls M, Urrútia Cuchi G et al. (2004) Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome. J Pain Symptom Manage 27, 360-369.
19. Miller JT, Btaiche IF (2009) Oxandrolone treatment in adults with severe thermal injury. Pharmacotherapy 29, 213-226.
20. Kurz A, Sessler DI (2003) Opioid-induced bowel dysfunction. Drugs 63, 649-671.
21. McMillan SC (2004) Assessing and managing opiate-induced constipation in adults with cancer. Cancer Control 11, 3 Suppl., 3-9. (Pubitemid 38756665)
22. Tassinari D, Sartori S, Tamburini E et al. (2008) Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a metaanalysis and systematic review of the literature. J Palliat Med 11, 492-501. (Pubitemid 351440551)
23. Holzer P (2008) New approaches to the treatment of opioidinduced constipation. Eur Rev Med Pharmacol Sci 12, Suppl. 1, 119-127.
24. Chassany O, Michaux A, Bergmann JF (2000) Druginduced diarrhoea. Drug Safety 22, 53-72.
25. Hill A, Balkin A (2009) Risk factors for gastrointestinal adverse events in HIV treated and untreated patients. AIDS Rev 11, 30-38.
26. Richardson G, Dobish R (2007) Chemotherapy induced diarrhea. J Oncol Pharm Pract 13, 181-198.
27. Edes TE, Walk BE, Austin JL (1990) Diarrhea in tubefed patients: feeding formula not necessarily the cause. Am J Med 88, 91-93. (Pubitemid 20051776)
28. Drewnowski A (1997) Taste preferences and food intake. Annu Rev Nutr 17, 237-253. (Pubitemid 27328800)
29. Nederfors T, Isaksson R, Mörnstad H et al. (1997) Prevalence of perceived symptoms of dry mouth in an adult Swedish population - relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol 25, 211-216. (Pubitemid 127534004)
30. Rozin P, Vollmecke TA (1986) Food likes and dislikes. Annu Rev Nutr 6, 433-456.
31. Bergdahl M, Bergdahl J (2002) Percieved taste disturbance in adults: prevalence and association with oral and psychological factors and medication. Clin Oral Investig 6, 145-149.
32. Heyneman CA (1996) Zinc deficiency and taste disorders. Ann Pharmacother 30, 186-187. (Pubitemid 26066687)
33. Moncrieff RW (1967) The Chemical Senses, 3rd ed. London: Leonard Hill.
34. Chu S, Downes JJ (2002) Proust nose best: odors are better cues of autobiographical memory. Mem Cognit 30, 511-518. (Pubitemid 34832955)
35. Yeomans MR (2006) Olfactory influences on appetite and satiety in humans. Physiol Behav 87, 800-804.
36. Mattes RD, Cowart BJ, Schiavo MA et al. (1990) Dietary evaluation of patients with smell and/or taste disorders. Am J Clin Nutr 51, 233-240.
37. Steinbach S, Hummel T, Böhner C et al. (2009) Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. Clin Oncol 27, 1899-1905.
38. Wismer WV (2008) Assessing alterations in taste and their impact on cancer care. Curr Opin Support Palliat Care 2, 282-287.
39. Cantú TG, Korek JS (1988) Monoamine oxidase inhibitors and weight gain. Drug Intell Clin Pharm 22, 755-759.
40. Welge-Luessen A, Wolfensberger M (2003) Reversible anosmia after amikacin therapy. Arch Otolaryngol Head Neck Surg 129, 1331-1333. (Pubitemid 37523109)
41. Maruyama T, Yasuda S, Odashiro K et al. (2007) Anosmia induced by amiodarone. Am J Med 120, e9. (Pubitemid 47633470)
42. Mair RG, Harrison LM (1991). Influence of drugs on smell function. In The Human Sense of Smell [DG Laing, RL Doty and W Breipohl, editors], chapter 16, pp. 335-359. Berlin: Springer-Verlag.
43. Bauer LO, Mott AE (1996) Differential effects of cocaine, alcohol, and nicotine dependence on olfactory evoked potentials. Drug Alcohol Depend 42, 21-26. (Pubitemid 26300636)
44. Bleasel AF, McLeod JG, Lane-Brown M (1990) Anosmia after doxycycline use. Med J Aust 152, 440. (Pubitemid 20127583)
45. Gudziol V, Mück-Weymann M, Seizinger O et al. (2007) Sildenafil affects olfactory function. J Urol 177, 258-261 (Pubitemid 44879474)